1. Home
  2. MLCO vs BHVN Comparison

MLCO vs BHVN Comparison

Compare MLCO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$5.32

Market Cap

2.2B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.00

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCO
BHVN
Founded
2003
2013
Country
Hong Kong
United States
Employees
N/A
274
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
MLCO
BHVN
Price
$5.32
$15.00
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$10.10
$29.08
AVG Volume (30 Days)
1.5M
2.7M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$4.37
N/A
P/E Ratio
$12.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.07
$7.48
52 Week High
$10.15
$18.57

Technical Indicators

Market Signals
Indicator
MLCO
BHVN
Relative Strength Index (RSI) 41.77 58.31
Support Level $5.13 $8.69
Resistance Level $5.73 $16.60
Average True Range (ATR) 0.17 1.12
MACD -0.03 0.24
Stochastic Oscillator 33.83 55.92

Price Performance

Historical Comparison
MLCO
BHVN

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: